ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Novel Approaches to Medication Teaching in Solid Organ Transplantation.

    D. Tsapepas, N. Jandovitz, S. Dulanya, D. Salerno, S. Hammad, P. Jordan.

    NewYork-Presbyterian Hospital, Columbia University, New York.

    Technology has become a fundamental part of our daily lives; mobile application (app) technologies enhance a healthcare providers ability to deliver patient-centered care. Solid organ…
  • 2016 American Transplant Congress

    Conversion to Once-Daily Tacrolimus in Stable Pediatric Liver Transplantation Recipients.

    N. Lee, S. Lee, C.-W. Cho, J. Lee, J. Lee, J. Kim, G.-S. Choi, C. Kwon, J.-W. Joh, S.-K. Lee.

    Department of Surgery Organ Transplant Center, Samsung Medical Center, Seoul, Republic of Korea.

    Purpose: Pediatric patients are known to have lower compliance than adult patients. Once-daily formulation of tacrolimus may increase compliance in pediatric liver transplant recipients. The…
  • 2016 American Transplant Congress

    Combined Liver-Kidney Transplantation in Children: Long-Term Follow-Up in 27 Children.

    M. Kemper,1 B. Nashan,2 L. Fischer,2 F. Brinkert.1

    1Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 2Hepatobiliary and Transplantation Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

    Combined liver and kidney transplantation (CLKT) is an important treatment option for patients suffering from diseases like autosomal recessive polycystic kidney disease (ARPKD) or primary…
  • 2016 American Transplant Congress

    Nuclear Factor of Activated T-Cells Post-Renal Transplant.

    K. Tornatore,1,4 K. Attwood,2 O. McGuire,3 K. O'Loughlin,3 R. Venuto,4 H. Minderman.3

    1Translational Pharmacology Research Center, School of Pharmacy, Buffalo; 2Biostatistics, School of Public Health, Buffalo; 3Flow Cytometry Laboratory, Roswell Park Cancer Institute, Buffalo; 4Medicine, School of Medicine, University at Buffalo, Buffalo.

    Background: Nuclear Factor of Activated T-cells (NFAT1) is a transcription factor regulating the expression of key targets involved with cellular immune function. Calcineurin is a…
  • 2016 American Transplant Congress

    Risk of Peritoneal Dialysis Catheter-Associated Peritonitis Following Kidney Transplant.

    A. Rizzi,1 S. Ruitta,1 J. Peterson,1 G. Gagin,1 D. Fritze,1 R. Sung,1 Y. Lu,2 K. Woodside.1

    1Department of Surgery, University of Michigan, Ann Arbor, MI; 2Department of Internal Medicine, University of Michigan, Ann Arbor, MI.

    While peritoneal dialysis (PD) has become more common, PD catheter management at the time of kidney transplant varies widely by transplant center. We sought to…
  • 2016 American Transplant Congress

    Concomitant Proton Pump Inhibitor and Mycophenolate Mofetil Use in Renal Transplant Recipients.

    K. Patel,1 B. Stephany,2 J. Barnes,1 S. Bauer,1 M. Spinner.1

    1Department of Pharmacy, Cleveland Clinic, Cleveland, OH; 2Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH.

    Pharmacokinetic (PK) data show reduced mycophenolic acid levels in transplant recipients taking mycophenolate mofetil (MMF) and proton pump inhibitors (PPIs) concomitantly. MMF dosing is not…
  • 2016 American Transplant Congress

    American and European Transplant Surgeons: Research, Teaching, and Burnout.

    M. Jesse,1 M. Abouljoud,1 A. Eshelman,1 C. DeReyck,2 J. Lerut.2

    1Transplant Institute, Henry Ford Health System, Detroit, MI; 2Cliniques Universitaires, Saint-Luc, Bruxelles, Belgium.

    Purpose: Examine whether location or research/teaching demands impacts burnout (emotional exhaustion, depersonalization, personal accomplishment).Method: Cross-sectional survey of American (US) and European (EU) organ transplant surgeons.Results:…
  • 2016 American Transplant Congress

    Liver Transplantation (LT) Using Liver Allografts from Deceased After Cardiac Death (DCD) Donors: Opinions, Practices and Reality.

    L. Sher,1 P. Abt,2 Y. Genyk,1 M. Lo,1 P. Yan,1 L. Ji,1 C. Marsh.3

    1Keck Hospital/University of Southern California, Los Angeles; 2Hospital of the University of Pennsylvania, Philadelphia; 3Scripps Clinic & Green Hospital, San Diego.

    Background: Scientific Studies Committee of ASTS conducted study to identify barriers to use of DCD liver grafts.Objectives: Identify barriers to use of DCD liver allografts;…
  • 2016 American Transplant Congress

    A New Diagnostic Score for Microvascular Inflammation in Antibody-Mediated Rejection in Heart Transplantation.

    M. Racapé,1 A. Loupy,2 R. Guillemain,1 A. François,3 P. Rouvier,4 C. Toquet,5 X. Jouven,1 J. Venner,6 L. Hidalgo,6 J. Reeve,6 P. Bruneval,1 J. Duong Van Huyen,2 P. Halloran.2

    1European Georges Pompidou Hospital, Paris, France; 2Necker Hospital, Paris, France; 3Rouen University Hospital, Rouen, France; 4La Pitié Salpêtrière Hospital, Paris, France; 5Laennec Hospital, Nantes, France; 6University of Alberta, Edmonton, Canada.

    BackgroundThe ISHLT working formulation defines Intravascular Activated Mononuclear Cells (IAMC) as one of the histopathologic features of antibody-mediated rejection (ABMR) in heart transplantation. However, no…
  • 2016 American Transplant Congress

    Ex Situ Perfusion of a Human Limb for 24 Hours.

    N. Werner,1 F. Alghanem,1 S. Rakestraw,1 B. Nicely,2 A. Olszewksi,2 S. Rudich,2 A. Rojas-Pena,1 J. Magee,1 K. Ozer.3

    1Transplant Surgery, University of Michigan, Ann Arbor, MI; 2Gift of Life Michigan, Ann Arbor, MI; 3Orthopedic Surgery, University of Michigan, Ann Arbor, MI.

    Background: Vascularized composite tissue (limb) allografts are procured and cold stored (4[deg]C) until surgery. This process is time limited as the tissue has to be…
  • « Previous Page
  • 1
  • …
  • 133
  • 134
  • 135
  • 136
  • 137
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences